Hepatitis Monthly

Official Journal of Research Center for Gastroenterology and Liver Diseases

Journal Information Boards and committees Indexing and Listing Sources Journal Metrics Open Peer Review (OPR)Publication Ethics and Malpractice Statement Reviewer and AE Registration Form Support Contact Us

APC

Authors Guide Submit Manuscript

Crossref

1. Impact of newer direct-acting antiviral drugs based on quality-adjusted life years

- Bhavya H. Vyas

- Nishita H. Darji

- Devang A. Rana

- Kaushal Y. Vyas

- Supriya D. Malhotra

2. Societal Economic Burden of Cystic Fibrosis in Iran: A Cost-of-Illness Study

- Hassan Karami

- Shideh Rafati

- Maryam Shirvani Shiri

- Ali Mouseli

- Hedayat Salari

- Amin Ghanbarnejad

- Mitra Nowrouzpour

- Fatemeh Noroozian

- Ali Alizadeh

- Fatemeh Asadi

- Narges Salehi

3. The Estimation of Economic Burden of Hepatitis B Virus Infection in Iran

- Mehdi Mohammadzadeh

- Behnaz Fattahi

- Tayebeh Ghari

4. Socio-economic assessments of Hepatitis C Virus infection: Evidence from Vehari district of Pakistan

- Ahmed Dilshad

- Shakeel Muhammad

- Tariq Bilal

- Mahmood Tariq

5. Elimination and Control of Viral Hepatitis B and C Infections Possible With Greater Attention to High Risk Groups

- Seyed Moayed Alavian

6. Improving access to the treatment of hepatitis C in low- and middle-income countries: evaluation of a patient assistance programme

- Salamat Ali

- Tofeeq Ur-Rehman

- Mashhood Ali

- Sayeed Haque

- Faisal Rasheed

- Eleri Lougher

- Muhammad Sarfraz Nawaz

- Vibhu Paudyal

7. Prevalence of HBV, HCV, and HIV Infections among Patients Undergoing Hemodialysis in Fasa, Iran: A Six-Year Follow-up Study

- Seyedeh Azra Shamsdin

- Mohamad Reza Fatahi

- Ali Reza Ansari

- Ali Reza Safarpour

8. Direct-Acting Antivirals Ombitasvir / Paritaprevir / Ritonavir + Dasabuvir with or Without Ribavirin in Hepatitis C Virus (HCV) Genotype 1-Infected Treatment-Naive or Treatment-Experienced Patients with or Without Cirrhosis: Real-Life Experience in Lithuania and Latvia

- Ligita Jancoriene

- Katazyna Polubenko

- Edita Kazenaite

- Arida Buivydiene

- Jolita Jakutiene

- Ieva Tolmane

- Agita Jeruma

- Daiva Radzisauskiene

- Evelina Mockiene

- Arvydas Ambrozaitis

9. Real World Cost-of-Illness Evidence in Hepatitis C Virus: A systematic review

- T. Joseph Mattingly

- Bryan L. Love

- Bilal Khokhar

10. Epidemiologic profile of viral hepatitis B and C in North of Iran: results from PERSIAN Guilan Cohort Study (PGCS)

- Fariborz Mansour-Ghanaei

- Farahnaz Joukar

- Mohammadreza Naghipour

- Soheil Hassanipour

- Sara Yeganeh

- Masood Sepehrimanesh

- Mohammad Fathalipour

11. Evaluating the Prevalence of HBV, HCV, and HIV in Hemodialysis Patients in North Cyprus

- Meryem Güvenir

- Emrah Guler

- Deren Oygar

- Ahmet Behlul

- Kaya Suer

12. The role of insurance providers in supporting treatment and management of hepatitis C patients

- Masoud Behzadifar

- Hasan Abolghasem Gorji

- Aziz Rezapour

- Meysam Behzadifar

- Nicola Luigi Bragazzi

13. Economic Burden of Inflammatory Bowel Disease in Shiraz, Iran

- Leila Rahmati

- Alireza Mooghali

- Seyed Mohammad Hosein Kamani

- Fatemeh Zare

- Hassan Askari

- Ali Reza Safarpour

14. Seronegative occult hepatitis C infection among hemodialysis patients: A prevalence study

- Shahab Mahmoudvand

- Somayeh Shokri

- Azarakhsh Azaran

- Seyed S. Seyedian

- Manoochehr Makvandi

- Habibollah Mirzaei

- Sheida B. Sheikhrobat

15. The Evaluation of Interferon Lambda 4 rs368234815 as a Predictor Factor in Treated Patients with Chronic Hepatitis C Genotype 1a Infection

- Shahram Jalilian

- Seyed Mahmoud Latifi

- Manoochehr Makvandi

- Ali Teimoori

- Azarakhsh Azaran

- Mehdi Parsanahad

- Gholamabas Kayedani

16. Hepatitis C virus-related policy-making in Iran: a stakeholder and social network analysis

- Masoud Behzadifar

- Hasan Abolghasem Gorji

- Aziz Rezapour

- Alireza Rezvanian

- Nicola Luigi Bragazzi

- Soudabeh Vatankhah

17. Towards hepatitis C virus elimination in Iran: A blueprint for comprehensive strategies

- SeyedehFatemeh Mousavi

- Maryam Alavi

- Alireza Delavari

- Hossein Poustchi

- Zahra Mohammadi

- Reza Malekzadeh

18. The Economic Burden of Viral hepatitis C infection at various stages of the disease in District Mardan, Pakistan

- Sajjad Khan

- Misbah Nosheen

19. Non-healthcare costs of hepatitis C: a systematic review

- Natàlia Pascual-Argente

- Jaume Puig-Junoy

- Anna Llagostera-Punzano

20. Economic Burden of Hepatitis C Infection

- Maria Stepanova

- Zobair M. Younossi

21. Seroepidemiology of Hepatitis C Among Drug Users at a Detoxification Center in Southeast China

- Dangui Zhang

- Xubin Zhang

- Lu Xu

- D. Lorne Tyrrell

- Michael Houghton

- William Ba-Thein

22. Cost-of-illness analysis of ulcerative colitis patients treated with biological therapy: a prospective observational study in Iran

- Hassan Karami

- Amin Ghanbarnejad

- Mitra Nowrouzpour

- Ali Mouseli

- Reihaneh Taheri Kondar

- Maryam Shirvani Shiri

- Farbod Ebadi Fard Azar

23. Clinical Efficacy and Safety of Direct-Acting Antivirals in Chronic Hepatitis C Treatment: Real-World Data

- Ayla Doğrugörün

- Elif Doyuk Kartal

- Saygın Nayman Alpat

24. Evaluation of Direct Acting Antivirals Efficiency in Turkish Patients with Chronic Hepatitis C Under Strict Rules

- Figen Sarıgul

- Murat Sayan

- Ulku User

- Nefise Oztoprak

25. Societal Economic Burden of Cystic Fibrosis in Iran: A Cost-of-Illness Study

- Hassan Karami

- Shideh Rafati

- Maryam Shiri

- Ali Mouseli

- Hedayat Salari

- Amin Ghanbarnejad

- Mitra Mowrouzpour

- Fatemeh Noroozian

- Ali Alizadeh

- Fatemeh Asadi

- Narges Salehi